PubMed:19940105
Annnotations
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_19940105_1_0 | 108-130 | expanded | denotes | Metabotropic glutamate |
| SS2_19940105_1_0 | 132-136 | abbr | denotes | mGlu |
| SS1_19940105_1_1 | 282-301 | expanded | denotes | Parkinson's disease |
| SS2_19940105_1_1 | 303-305 | abbr | denotes | PD |
| AE1_19940105_1_0 | SS1_19940105_1_0 | SS2_19940105_1_0 | abbreviatedTo | Metabotropic glutamate,mGlu |
| AE1_19940105_1_1 | SS1_19940105_1_1 | SS2_19940105_1_1 | abbreviatedTo | Parkinson's disease,PD |
bc5cdr-valid-experiment
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-22 | Chemical | denotes | glutamate |
| T2 | 87-106 | Disease | denotes | Parkinson's disease |
| T3 | 121-130 | Chemical | denotes | glutamate |
| T4 | 282-301 | Disease | denotes | Parkinson's disease |
| T5 | 303-305 | Disease | denotes | PD |
| T6 | 471-473 | Disease | denotes | PD |
| T7 | 503-554 | Chemical | denotes | N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride |
| T8 | 556-562 | Chemical | denotes | AMN082 |
| T9 | 673-675 | Disease | denotes | PD |
| T10 | 765-771 | Chemical | denotes | AMN082 |
| T11 | 781-792 | Chemical | denotes | haloperidol |
| T12 | 801-810 | Disease | denotes | catalepsy |
| T13 | 820-826 | Chemical | denotes | AMN082 |
| T14 | 853-864 | Chemical | denotes | apomorphine |
| T15 | 897-914 | Chemical | denotes | 6-hydroxydopamine |
| T16 | 916-922 | Chemical | denotes | 6-OHDA |
| T17 | 994-1002 | Disease | denotes | akinetic |
| T18 | 1015-1017 | Disease | denotes | PD |
| T19 | 1036-1042 | Chemical | denotes | AMN082 |
| T20 | 1113-1119 | Chemical | denotes | 6-OHDA |
| T21 | 1148-1154 | Chemical | denotes | AMN082 |
| T22 | 1179-1190 | Chemical | denotes | haloperidol |
| T23 | 1199-1208 | Disease | denotes | catalepsy |
| T24 | 1313-1319 | Chemical | denotes | AMN082 |
| T25 | 1380-1382 | Disease | denotes | PD |
| T26 | 1500-1508 | Chemical | denotes | dopamine |
bc5cdr-valid-deepseek-nr-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-41 | Chemical | denotes | Metabotropic glutamate 7 receptor subtype |
| T2 | 87-106 | Disease | denotes | Parkinson's disease |
| T3 | 108-137 | Chemical | denotes | Metabotropic glutamate (mGlu) |
| T4 | 282-306 | Disease | denotes | Parkinson's disease (PD) |
| T5 | 348-362 | Chemical | denotes | mGlu7 receptor |
| T6 | 503-563 | Chemical | denotes | N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride (AMN082) |
| T7 | 609-624 | Chemical | denotes | mGlu7 receptors |
| T8 | 765-771 | Chemical | denotes | AMN082 |
| T9 | 781-792 | Chemical | denotes | haloperidol |
| T10 | 853-864 | Chemical | denotes | apomorphine |
| T11 | 897-923 | Chemical | denotes | 6-hydroxydopamine (6-OHDA) |
| T12 | 1036-1042 | Chemical | denotes | AMN082 |
| T13 | 1214-1228 | Chemical | denotes | mGlu7 receptor |
bc5cdr-valid-gemini-r-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-22 | Chemical | denotes | glutamate |
| T2 | 87-106 | Disease | denotes | Parkinson's disease |
| T3 | 121-130 | Chemical | denotes | glutamate |
| T4 | 282-301 | Disease | denotes | Parkinson's disease |
| T5 | 303-305 | Disease | denotes | PD |
| T6 | 471-473 | Disease | denotes | PD |
| T7 | 503-554 | Chemical | denotes | N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride |
| T8 | 556-562 | Chemical | denotes | AMN082 |
| T9 | 673-675 | Disease | denotes | PD |
| T10 | 765-771 | Chemical | denotes | AMN082 |
| T11 | 781-792 | Chemical | denotes | haloperidol |
| T12 | 801-810 | Disease | denotes | catalepsy |
| T13 | 820-826 | Chemical | denotes | AMN082 |
| T14 | 853-864 | Chemical | denotes | apomorphine |
| T15 | 897-914 | Chemical | denotes | 6-hydroxydopamine |
| T16 | 916-922 | Chemical | denotes | 6-OHDA |
| T17 | 1015-1017 | Disease | denotes | PD |
| T18 | 1036-1042 | Chemical | denotes | AMN082 |
| T19 | 1148-1154 | Chemical | denotes | AMN082 |
| T20 | 1179-1190 | Chemical | denotes | haloperidol |
| T21 | 1199-1208 | Disease | denotes | catalepsy |
| T22 | 1380-1382 | Disease | denotes | PD |
| T23 | 1458-1475 | Disease | denotes | motor dysfunction |
| T24 | 1500-1508 | Chemical | denotes | dopamine |
bc5cdr-valid-gemini-r-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-22 | Chemical | denotes | glutamate |
| T2 | 52-66 | Disease | denotes | motor symptoms |
| T3 | 87-106 | Disease | denotes | Parkinson's disease |
| T4 | 121-130 | Chemical | denotes | glutamate |
| T5 | 282-301 | Disease | denotes | Parkinson's disease |
| T6 | 303-305 | Disease | denotes | PD |
| T7 | 471-473 | Disease | denotes | PD |
| T8 | 503-554 | Chemical | denotes | N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride |
| T9 | 556-562 | Chemical | denotes | AMN082 |
| T10 | 673-675 | Disease | denotes | PD |
| T11 | 765-771 | Chemical | denotes | AMN082 |
| T12 | 781-792 | Chemical | denotes | haloperidol |
| T13 | 801-810 | Disease | denotes | catalepsy |
| T14 | 820-826 | Chemical | denotes | AMN082 |
| T15 | 853-864 | Chemical | denotes | apomorphine |
| T16 | 897-914 | Chemical | denotes | 6-hydroxydopamine |
| T17 | 916-922 | Chemical | denotes | 6-OHDA |
| T18 | 994-1011 | Disease | denotes | akinetic symptoms |
| T19 | 1015-1017 | Disease | denotes | PD |
| T20 | 1458-1475 | Disease | denotes | motor dysfunction |
bc5cdr-valid-gemini-nr-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-22 | Chemical | denotes | glutamate |
| T2 | 87-106 | Disease | denotes | Parkinson's disease |
| T3 | 121-130 | Chemical | denotes | glutamate |
| T4 | 282-301 | Disease | denotes | Parkinson's disease |
| T5 | 303-305 | Disease | denotes | PD |
| T6 | 503-554 | Chemical | denotes | N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride |
| T7 | 556-562 | Chemical | denotes | AMN082 |
| T8 | 673-675 | Disease | denotes | PD |
| T9 | 765-771 | Chemical | denotes | AMN082 |
| T10 | 781-792 | Chemical | denotes | haloperidol |
| T11 | 801-810 | Disease | denotes | catalepsy |
| T12 | 820-826 | Chemical | denotes | AMN082 |
| T13 | 853-864 | Chemical | denotes | apomorphine |
| T14 | 897-914 | Chemical | denotes | 6-hydroxydopamine |
| T15 | 916-922 | Chemical | denotes | 6-OHDA |
| T16 | 994-1002 | Disease | denotes | akinetic |
| T17 | 1015-1017 | Disease | denotes | PD |
| T18 | 1036-1042 | Chemical | denotes | AMN082 |
| T19 | 1148-1154 | Chemical | denotes | AMN082 |
| T20 | 1179-1190 | Chemical | denotes | haloperidol |
| T21 | 1199-1208 | Disease | denotes | catalepsy |
| T22 | 1380-1382 | Disease | denotes | PD |
| T23 | 1458-1475 | Disease | denotes | motor dysfunction |
| T24 | 1500-1508 | Chemical | denotes | dopamine |
| T25 | 1633-1649 | Disease | denotes | antiparkinsonian |
bc5cdr-valid-gemini-nr-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-22 | Chemical | denotes | glutamate |
| T2 | 87-106 | Disease | denotes | Parkinson's disease |
| T3 | 108-130 | Chemical | denotes | Metabotropic glutamate |
| T4 | 282-301 | Disease | denotes | Parkinson's disease |
| T5 | 303-305 | Disease | denotes | PD |
| T6 | 471-473 | Disease | denotes | PD |
| T7 | 503-554 | Chemical | denotes | N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride |
| T8 | 556-562 | Chemical | denotes | AMN082 |
| T9 | 673-675 | Disease | denotes | PD |
| T10 | 781-792 | Chemical | denotes | haloperidol |
| T11 | 801-810 | Disease | denotes | catalepsy |
| T12 | 820-826 | Chemical | denotes | AMN082 |
| T13 | 853-864 | Chemical | denotes | apomorphine |
| T14 | 897-914 | Chemical | denotes | 6-hydroxydopamine |
| T15 | 916-922 | Chemical | denotes | 6-OHDA |
| T16 | 1015-1017 | Disease | denotes | PD |
| T17 | 1036-1042 | Chemical | denotes | AMN082 |
| T18 | 1148-1154 | Chemical | denotes | AMN082 |
| T19 | 1500-1508 | Chemical | denotes | dopamine |
bc5cdr-valid
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-22 | Chemical | denotes | glutamate |
| T2 | 87-106 | Disease | denotes | Parkinson's disease |
| T3 | 121-130 | Chemical | denotes | glutamate |
| T4 | 282-301 | Disease | denotes | Parkinson's disease |
| T5 | 303-305 | Disease | denotes | PD |
| T6 | 471-473 | Disease | denotes | PD |
| T7 | 503-554 | Chemical | denotes | N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride |
| T8 | 556-562 | Chemical | denotes | AMN082 |
| T9 | 673-675 | Disease | denotes | PD |
| T10 | 765-771 | Chemical | denotes | AMN082 |
| T11 | 781-792 | Chemical | denotes | haloperidol |
| T12 | 801-810 | Disease | denotes | catalepsy |
| T13 | 820-826 | Chemical | denotes | AMN082 |
| T14 | 853-864 | Chemical | denotes | apomorphine |
| T15 | 897-914 | Chemical | denotes | 6-hydroxydopamine |
| T16 | 916-922 | Chemical | denotes | 6-OHDA |
| T17 | 994-1002 | Disease | denotes | akinetic |
| T18 | 1015-1017 | Disease | denotes | PD |
| T19 | 1036-1042 | Chemical | denotes | AMN082 |
| T20 | 1113-1119 | Chemical | denotes | 6-OHDA |
| T21 | 1148-1154 | Chemical | denotes | AMN082 |
| T22 | 1179-1190 | Chemical | denotes | haloperidol |
| T23 | 1199-1208 | Disease | denotes | catalepsy |
| T24 | 1313-1319 | Chemical | denotes | AMN082 |
| T25 | 1380-1382 | Disease | denotes | PD |
| T26 | 1500-1508 | Chemical | denotes | dopamine |
bc5cdr-valid-gpt-nr-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 87-106 | Disease | denotes | Parkinson's disease |
| T2 | 282-301 | Disease | denotes | Parkinson's disease |
bc5cdr-valid-deepseek-r-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 87-106 | Disease | denotes | Parkinson's disease |
| T2 | 303-305 | Disease | denotes | PD |
| T3 | 471-473 | Disease | denotes | PD |
| T4 | 503-554 | Chemical | denotes | N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride |
| T5 | 556-562 | Chemical | denotes | AMN082 |
| T6 | 781-792 | Chemical | denotes | haloperidol |
| T7 | 853-864 | Chemical | denotes | apomorphine |
| T8 | 897-914 | Chemical | denotes | 6-hydroxydopamine |
| T9 | 916-922 | Chemical | denotes | 6-OHDA |
bc5cdr-valid-gpt-r-ng
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-22 | Chemical | denotes | glutamate |
| T2 | 87-106 | Disease | denotes | Parkinson's disease |
| T3 | 121-130 | Chemical | denotes | glutamate |
| T4 | 282-301 | Disease | denotes | Parkinson's disease |
| T5 | 303-305 | Disease | denotes | PD |
| T6 | 471-473 | Disease | denotes | PD |
| T7 | 503-554 | Chemical | denotes | N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride |
| T8 | 556-562 | Chemical | denotes | AMN082 |
| T9 | 673-675 | Disease | denotes | PD |
| T10 | 765-771 | Chemical | denotes | AMN082 |
| T11 | 781-792 | Chemical | denotes | haloperidol |
| T12 | 801-810 | Disease | denotes | catalepsy |
| T13 | 820-826 | Chemical | denotes | AMN082 |
| T14 | 853-864 | Chemical | denotes | apomorphine |
| T15 | 897-914 | Chemical | denotes | 6-hydroxydopamine |
| T16 | 916-922 | Chemical | denotes | 6-OHDA |
| T17 | 1015-1017 | Disease | denotes | PD |
| T18 | 1036-1042 | Chemical | denotes | AMN082 |
| T19 | 1113-1119 | Chemical | denotes | 6-OHDA |
| T20 | 1148-1154 | Chemical | denotes | AMN082 |
| T21 | 1179-1190 | Chemical | denotes | haloperidol |
| T22 | 1199-1208 | Disease | denotes | catalepsy |
| T23 | 1313-1319 | Chemical | denotes | AMN082 |
| T24 | 1380-1382 | Disease | denotes | PD |
| T25 | 1500-1508 | Chemical | denotes | dopamine |
bc5cdr-valid-gpt-nr-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 87-106 | Disease | denotes | Parkinson's disease |
| T2 | 282-301 | Disease | denotes | Parkinson's disease |
| T3 | 303-305 | Disease | denotes | PD |
| T4 | 471-473 | Disease | denotes | PD |
| T5 | 503-554 | Chemical | denotes | N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride |
| T6 | 556-562 | Chemical | denotes | AMN082 |
| T7 | 673-675 | Disease | denotes | PD |
| T8 | 765-771 | Chemical | denotes | AMN082 |
| T9 | 781-792 | Chemical | denotes | haloperidol |
| T10 | 801-810 | Disease | denotes | catalepsy |
| T11 | 820-826 | Chemical | denotes | AMN082 |
| T12 | 853-864 | Chemical | denotes | apomorphine |
| T13 | 897-914 | Chemical | denotes | 6-hydroxydopamine |
| T14 | 916-922 | Chemical | denotes | 6-OHDA |
| T15 | 994-1011 | Disease | denotes | akinetic symptoms |
| T16 | 1015-1017 | Disease | denotes | PD |
| T17 | 1036-1042 | Chemical | denotes | AMN082 |
| T18 | 1113-1119 | Chemical | denotes | 6-OHDA |
| T19 | 1148-1154 | Chemical | denotes | AMN082 |
| T20 | 1179-1190 | Chemical | denotes | haloperidol |
| T21 | 1199-1208 | Disease | denotes | catalepsy |
| T22 | 1313-1319 | Chemical | denotes | AMN082 |
| T23 | 1380-1382 | Disease | denotes | PD |
| T24 | 1458-1475 | Disease | denotes | motor dysfunction |
| T25 | 1500-1508 | Chemical | denotes | dopamine |
bc5cdr-valid-gpt-r-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 87-106 | Disease | denotes | Parkinson's disease |
| T2 | 282-301 | Disease | denotes | Parkinson's disease |
| T3 | 303-305 | Disease | denotes | PD |
| T4 | 471-473 | Disease | denotes | PD |
| T5 | 503-554 | Chemical | denotes | N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride |
| T6 | 556-562 | Chemical | denotes | AMN082 |
| T7 | 673-675 | Disease | denotes | PD |
| T8 | 765-771 | Chemical | denotes | AMN082 |
| T9 | 781-792 | Chemical | denotes | haloperidol |
| T10 | 801-810 | Disease | denotes | catalepsy |
| T11 | 820-826 | Chemical | denotes | AMN082 |
| T12 | 853-864 | Chemical | denotes | apomorphine |
| T13 | 897-914 | Chemical | denotes | 6-hydroxydopamine |
| T14 | 916-922 | Chemical | denotes | 6-OHDA |
| T15 | 1015-1017 | Disease | denotes | PD |
| T16 | 1036-1042 | Chemical | denotes | AMN082 |
| T17 | 1113-1119 | Chemical | denotes | 6-OHDA |
| T18 | 1148-1154 | Chemical | denotes | AMN082 |
| T19 | 1179-1190 | Chemical | denotes | haloperidol |
| T20 | 1199-1208 | Disease | denotes | catalepsy |
| T21 | 1313-1319 | Chemical | denotes | AMN082 |
| T22 | 1380-1382 | Disease | denotes | PD |
| T23 | 1500-1508 | Chemical | denotes | dopamine |
bc5cdr-valid-gemini-r-m
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-22 | Chemical | denotes | glutamate |
| T2 | 52-66 | Disease | denotes | motor symptoms |
| T3 | 87-106 | Disease | denotes | Parkinson's disease |
| T4 | 121-130 | Chemical | denotes | glutamate |
| T5 | 282-301 | Disease | denotes | Parkinson's disease |
| T6 | 303-305 | Disease | denotes | PD |
| T7 | 471-473 | Disease | denotes | PD |
| T8 | 503-554 | Chemical | denotes | N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride |
| T9 | 556-562 | Chemical | denotes | AMN082 |
| T10 | 673-675 | Disease | denotes | PD |
| T11 | 765-771 | Chemical | denotes | AMN082 |
| T12 | 781-792 | Chemical | denotes | haloperidol |
| T13 | 801-810 | Disease | denotes | catalepsy |
| T14 | 820-826 | Chemical | denotes | AMN082 |
| T15 | 853-864 | Chemical | denotes | apomorphine |
| T16 | 873-882 | Disease | denotes | rotations |
| T17 | 897-914 | Chemical | denotes | 6-hydroxydopamine |
| T18 | 916-922 | Chemical | denotes | 6-OHDA |
| T19 | 994-1011 | Disease | denotes | akinetic symptoms |
| T20 | 1015-1017 | Disease | denotes | PD |
| T21 | 1036-1042 | Chemical | denotes | AMN082 |
| T22 | 1148-1154 | Chemical | denotes | AMN082 |
| T23 | 1179-1190 | Chemical | denotes | haloperidol |
| T24 | 1199-1208 | Disease | denotes | catalepsy |
| T25 | 1380-1382 | Disease | denotes | PD |
| T26 | 1458-1475 | Disease | denotes | motor dysfunction |
| T27 | 1500-1508 | Chemical | denotes | dopamine |
bc5cdr-valid-gpt-r-m2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 87-106 | Disease | denotes | Parkinson's disease |
| T2 | 282-301 | Disease | denotes | Parkinson's disease |
| T3 | 303-305 | Disease | denotes | PD |
| T4 | 471-473 | Disease | denotes | PD |
| T5 | 503-554 | Chemical | denotes | N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride |
| T6 | 556-562 | Chemical | denotes | AMN082 |
| T7 | 673-675 | Disease | denotes | PD |
| T8 | 765-771 | Chemical | denotes | AMN082 |
| T9 | 781-792 | Chemical | denotes | haloperidol |
| T10 | 801-810 | Disease | denotes | catalepsy |
| T11 | 820-826 | Chemical | denotes | AMN082 |
| T12 | 853-864 | Chemical | denotes | apomorphine |
| T13 | 897-914 | Chemical | denotes | 6-hydroxydopamine |
| T14 | 916-922 | Chemical | denotes | 6-OHDA |
| T15 | 994-1002 | Disease | denotes | akinetic |
| T16 | 1015-1017 | Disease | denotes | PD |
| T17 | 1036-1042 | Chemical | denotes | AMN082 |
| T18 | 1113-1119 | Chemical | denotes | 6-OHDA |
| T19 | 1148-1154 | Chemical | denotes | AMN082 |
| T20 | 1179-1190 | Chemical | denotes | haloperidol |
| T21 | 1199-1208 | Disease | denotes | catalepsy |
| T22 | 1313-1319 | Chemical | denotes | AMN082 |
| T23 | 1380-1382 | Disease | denotes | PD |
| T24 | 1500-1508 | Chemical | denotes | dopamine |
bc5cdr-valid-deepseek-r-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 13-22 | Chemical | denotes | glutamate |
| T2 | 87-106 | Disease | denotes | Parkinson's disease |
| T3 | 121-130 | Chemical | denotes | glutamate |
| T4 | 282-301 | Disease | denotes | Parkinson's disease |
| T5 | 303-305 | Disease | denotes | PD |
| T6 | 471-473 | Disease | denotes | PD |
| T7 | 503-554 | Chemical | denotes | N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride |
| T8 | 556-562 | Chemical | denotes | AMN082 |
| T9 | 673-675 | Disease | denotes | PD |
| T10 | 765-771 | Chemical | denotes | AMN082 |
| T11 | 781-792 | Chemical | denotes | haloperidol |
| T12 | 801-810 | Disease | denotes | catalepsy |
| T13 | 853-864 | Chemical | denotes | apomorphine |
| T14 | 897-914 | Chemical | denotes | 6-hydroxydopamine |
| T15 | 916-922 | Chemical | denotes | 6-OHDA |
bc5cdr-valid-deepseek-nr-g
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-41 | Chemical | denotes | Metabotropic glutamate 7 receptor subtype |
| T2 | 87-106 | Disease | denotes | Parkinson's disease |
| T3 | 108-130 | Chemical | denotes | Metabotropic glutamate |
| T4 | 132-136 | Chemical | denotes | mGlu |
| T5 | 282-301 | Disease | denotes | Parkinson's disease |
| T6 | 303-305 | Disease | denotes | PD |
| T7 | 348-353 | Chemical | denotes | mGlu7 |
| T8 | 471-473 | Disease | denotes | PD |
| T9 | 503-554 | Chemical | denotes | N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride |
| T10 | 556-562 | Chemical | denotes | AMN082 |
| T11 | 609-614 | Chemical | denotes | mGlu7 |
| T12 | 673-675 | Disease | denotes | PD |
| T13 | 765-771 | Chemical | denotes | AMN082 |
| T14 | 781-792 | Chemical | denotes | haloperidol |
| T15 | 801-810 | Disease | denotes | catalepsy |
| T16 | 820-826 | Chemical | denotes | AMN082 |
| T17 | 853-864 | Chemical | denotes | apomorphine |
| T18 | 873-882 | Disease | denotes | rotations |
| T19 | 897-914 | Chemical | denotes | 6-hydroxydopamine |
| T20 | 916-922 | Chemical | denotes | 6-OHDA |
| T21 | 1015-1017 | Disease | denotes | PD |
| T22 | 1036-1042 | Chemical | denotes | AMN082 |
| T23 | 1214-1219 | Chemical | denotes | mGlu7 |
bc5cdr-valid-deepseek-r-m
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 87-106 | Disease | denotes | Parkinson's disease |
| T2 | 303-305 | Disease | denotes | PD |
| T3 | 471-473 | Disease | denotes | PD |
| T4 | 503-554 | Chemical | denotes | N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride |
| T5 | 556-562 | Chemical | denotes | AMN082 |
| T6 | 673-675 | Disease | denotes | PD |
| T7 | 781-792 | Chemical | denotes | haloperidol |
| T8 | 801-810 | Disease | denotes | catalepsy |
| T9 | 853-864 | Chemical | denotes | apomorphine |
| T10 | 897-914 | Chemical | denotes | 6-hydroxydopamine |
| T11 | 916-922 | Chemical | denotes | 6-OHDA |
bc5cdr-valid-gpt-r-m
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 87-106 | Disease | denotes | Parkinson's disease |
| T2 | 282-301 | Disease | denotes | Parkinson's disease |
| T3 | 303-305 | Disease | denotes | PD |
| T4 | 471-473 | Disease | denotes | PD |
| T5 | 503-554 | Chemical | denotes | N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride |
| T6 | 556-562 | Chemical | denotes | AMN082 |
| T7 | 673-675 | Disease | denotes | PD |
| T8 | 765-771 | Chemical | denotes | AMN082 |
| T9 | 781-792 | Chemical | denotes | haloperidol |
| T10 | 801-810 | Disease | denotes | catalepsy |
| T11 | 820-826 | Chemical | denotes | AMN082 |
| T12 | 853-864 | Chemical | denotes | apomorphine |
| T13 | 897-914 | Chemical | denotes | 6-hydroxydopamine |
| T14 | 916-922 | Chemical | denotes | 6-OHDA |
| T15 | 1015-1017 | Disease | denotes | PD |
| T16 | 1036-1042 | Chemical | denotes | AMN082 |
| T17 | 1113-1119 | Chemical | denotes | 6-OHDA |
| T18 | 1148-1154 | Chemical | denotes | AMN082 |
| T19 | 1179-1190 | Chemical | denotes | haloperidol |
| T20 | 1199-1208 | Disease | denotes | catalepsy |
| T21 | 1313-1319 | Chemical | denotes | AMN082 |
| T22 | 1380-1382 | Disease | denotes | PD |
| T23 | 1500-1508 | Chemical | denotes | dopamine |